Revvity | PKI - Interest Expense On Debt


Revvity reported $24.72M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Agilent USD 25M 0 Mar/2026
Align Technology USD 16.04M 14.04M Dec/2025
Bio Techne USD 2.17M 9K Dec/2025
Bio-Rad Laboratories USD 12.1M 200K Dec/2025
Bruker USD 8.1M 11.9M Dec/2025
Celltrion KRW 19B 1.96B Jun/2025
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Danaher USD 63M 8M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Mar/2026
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Illumina USD 26M 1000K Dec/2025
Intuitive Surgical USD 20.11B 58.39B Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Laboratory Of America USD 55.1M 100K Mar/2026
Medical Developments International AUD 18K 3K Jun/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Qiagen NV USD 10.14M 1.92M Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.58M 83K Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
Waters USD 42M 33.38M Mar/2026
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025